Publications by authors named "Norma Peter"

Claim this Profile
D
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Peter Dreger, Norma Peter, Peter Staib

Ann Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross, Sebastian Scholl, Norma Peter

Ann Hematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross, Sebastian Scholl, Norma Peter

Ann Hematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Olivier Hermine, Eva Hoster, Jan Walewski, André Bosly, Stephan Stilgenbauer, Norma Peter

Lancet· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.
Elias K Mai, Axel Benner, Uta Bertsch, Peter Brossart, Annette Hänel, Norma Peter

Br J Haematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
Sebastian Kirschey, Thomas Flohr, Hans H Wolf, Norbert Frickhofen, Martin Gramatzki, Norma Peter

Br J Haematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Christof Scheid, Pieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Norma Peter

Haematologica· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Norbert Schmitz, Maike Nickelsen, Marita Ziepert, Mathias Haenel, Peter Borchmann, Norma Peter

Lancet Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.
Carsten Müller, Niels Murawski, Martin H J Wiesen, Gerhard Held, Viola Poeschel, Norma Peter

Blood· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.
Kai Neben, Henk M Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Norma Peter

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Norbert Schmitz, Lorenz Trümper, Marita Ziepert, Maike Nickelsen, Anthony D Ho, Norma Peter

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of overall survival in advanced stage mantle cell lymphoma.
Annina Herrmann, Eva Hoster, Thomas Zwingers, Günter Brittinger, Marianne Engelhard, Peter Meusers, Norma Peter

J Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Carsten Zwick, Josef Birkmann, Norma Peter, Heinrich Bodenstein, Roland Fuchs

Ann Hematol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Michael Pfreundschuh, Joerg Schubert, Marita Ziepert, Rudolf Schmits, Martin Mohren, Norma Peter

Lancet Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
Eva Hoster, Martin Dreyling, Wolfram Klapper, Christian Gisselbrecht, Achiel van Hoof, Norma Peter

Blood· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma.
Jan-Peter Glossmann, Jan Oliver Staak, Lucia Nogova, Volker Diehl, Christoph Scheid, Norma Peter

Ann Hematol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis